{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T21:33:59Z","timestamp":1793050439485,"version":"4.5.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"vor","delay-in-days":27,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012276","name":"Tillotts Pharma AG","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012276","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.cgh.2026.07.022","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T23:25:22Z","timestamp":1785453922000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Epidemiologic, Clinical, and Psychological Characteristics of Individuals With Self-Reported Irritable Bowel Syndrome Based on the Rome V vs Rome IV Criteria"],"prefix":"10.1016","author":[{"given":"Kyle","family":"Staller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek C.","family":"Goodoory","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cho Ee","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6371-4359","authenticated-orcid":false,"given":"Alexander C.","family":"Ford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Black","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2026.07.022_bib1","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1053\/j.gastro.2020.04.014","article-title":"Worldwide prevalence and burden of functional gastrointestinal disorders, results of Rome Foundation Global Study","volume":"160","author":"Sperber","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2026.07.022_bib2","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1016\/S0140-6736(20)31548-8","article-title":"Irritable bowel syndrome","volume":"396","author":"Ford","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.cgh.2026.07.022_bib3","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S2468-1253(16)30023-1","article-title":"Pathophysiology of irritable bowel syndrome","volume":"1","author":"Holtmann","year":"2016","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2026.07.022_bib4","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1093\/fampra\/17.2.108","article-title":"Medical and lay views of irritable bowel syndrome","volume":"17","author":"Dixon-Woods","year":"2000","journal-title":"Fam Pract"},{"key":"10.1016\/j.cgh.2026.07.022_bib5","first-page":"159","article-title":"Identification of sub-groups of functional gastrointestinal disorders","volume":"3","author":"Drossman","year":"1990","journal-title":"Gastroenterol Int"},{"key":"10.1016\/j.cgh.2026.07.022_bib6","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1053\/j.gastro.2026.02.003","article-title":"Bowel disorders","volume":"170","author":"Corsetti","year":"2026","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2026.07.022_bib7","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1053\/j.gastro.2016.02.031","article-title":"Bowel disorders","volume":"150","author":"Mearin","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2026.07.022_bib8","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1053\/j.gastro.2005.11.061","article-title":"Functional bowel disorders","volume":"130","author":"Longstreth","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2026.07.022_bib9","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.cgh.2019.05.037","article-title":"Epidemiological, clinical, and psychological characteristics of individuals with self-reported irritable bowel syndrome based on the Rome IV vs Rome III criteria","volume":"18","author":"Black","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2026.07.022_bib10","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1053\/j.gastro.2019.12.021","article-title":"Prevalence of Rome IV functional bowel disorders among adults in the United States, Canada, and the United Kingdom","volume":"158","author":"Palsson","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2026.07.022_bib11","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.13189","article-title":"Rome III vs Rome IV criteria for irritable bowel syndrome: a comparison of clinical characteristics in a large cohort study","volume":"30","author":"Vork","year":"2018","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.cgh.2026.07.022_bib12","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1136\/gut.2007.119446","article-title":"Guidelines on the irritable bowel syndrome: mechanisms and practical management","volume":"56","author":"Spiller","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2026.07.022_bib13","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/apt.17356","article-title":"Factors associated with lower disease-specific and generic health-related quality of life in Rome IV irritable bowel syndrome","volume":"57","author":"Goodoory","year":"2023","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2026.07.022_bib14","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1111\/apt.16816","article-title":"Willingness to accept risk with medication in return for cure of symptoms among patients with Rome IV irritable bowel syndrome","volume":"55","author":"Goodoory","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2026.07.022_bib15","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/apt.16939","article-title":"Direct healthcare costs of Rome IV or Rome III-defined irritable bowel syndrome in the United Kingdom","volume":"56","author":"Goodoory","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2026.07.022_bib16","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/apt.17132","article-title":"Impact of Rome IV irritable bowel syndrome on work and activities of daily living","volume":"56","author":"Goodoory","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2026.07.022_bib17","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1053\/j.gastro.2026.01.041","article-title":"Development of the Rome V diagnostic questionnaires","volume":"170","author":"Palsson","year":"2026","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2026.07.022_bib18","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/S2468-1253(26)00118-4","article-title":"The Rome V criteria for the diagnosis of irritable bowel syndrome in secondary care: a diagnostic accuracy study","volume":"11","author":"Staller","year":"2026","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2026.07.022_bib19","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/s41395-018-0074-z","article-title":"How the change in IBS criteria from Rome III to Rome IV impacts on clinical characteristics and key pathophysiological factors","volume":"113","author":"Aziz","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2026.07.022_bib20","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1111\/jgh.13642","article-title":"Comparison of the Rome IV and Rome III criteria for IBS diagnosis: a cross-sectional survey","volume":"32","author":"Bai","year":"2017","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2026.07.022_bib21","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.jclinepi.2008.02.001","article-title":"Randomized patients in IBS research had different disease characteristics compared to eligible and recruited patients","volume":"61","author":"Bijkerk","year":"2008","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.cgh.2026.07.022_bib22","doi-asserted-by":"crossref","first-page":"362","DOI":"10.14309\/ajg.0000000000000946","article-title":"Symptom stability in Rome IV vs Rome III irritable bowel syndrome","volume":"116","author":"Barberio","year":"2021","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2026.07.022_bib23","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1177\/1756283X12442223","article-title":"Irritable bowel syndrome: how useful is the term and the 'diagnosis'?","volume":"5","author":"Camilleri","year":"2012","journal-title":"Ther Adv Gastroenterol"},{"key":"10.1016\/j.cgh.2026.07.022_bib24","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12876-022-02118-y","article-title":"Overlap between irritable bowel syndrome and common gastrointestinal diagnoses: a retrospective cohort study of 29,553 outpatients in Germany","volume":"22","author":"Loosen","year":"2022","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.cgh.2026.07.022_bib25","doi-asserted-by":"crossref","first-page":"5787","DOI":"10.3390\/jcm12185787","article-title":"Misinterpreting diarrhea-predominant irritable bowel syndrome and functional diarrhea: pathophysiological highlights","volume":"12","author":"Sciume","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.cgh.2026.07.022_bib26","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.cgh.2021.04.043","article-title":"Natural history and disease impact of Rome IV Vs Rome III irritable bowel syndrome: a longitudinal follow-up study","volume":"20","author":"Goodoory","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2026.07.022_bib27","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1136\/gutjnl-2021-324598","article-title":"British Society of Gastroenterology guidelines on the management of irritable bowel syndrome","volume":"70","author":"Vasant","year":"2021","journal-title":"Gut"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154235652600563X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154235652600563X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:38:54Z","timestamp":1793047134000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S154235652600563X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":27,"alternative-id":["S154235652600563X"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2026.07.022","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epidemiologic, Clinical, and Psychological Characteristics of Individuals With Self-Reported Irritable Bowel Syndrome Based on the Rome V vs Rome IV Criteria","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2026.07.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of American Gastroenterological Association Institute.","name":"copyright","label":"Copyright"}]}}